Search Article Keyword:  

 PubMed Submission Abstract PDF  Cover Contents Editorial Board Count: 2513 Download Count: 577 

ISSN 1007-9327 CN 14-1219/R  World J Gastroenterol  2008 December 28; 14(48): 7321-7328


Scutellaria barbate extract induces apoptosis of hepatoma H22 cells via the mitochondrial pathway involving caspase-3

Zhi-Jun Dai, Xi-Jing Wang, Zong-Fang Li, Zong-Zheng Ji, Hong-Tao Ren, Wei Tang, Xiao-Xu Liu, Hua-Feng Kang,

Hai-Tao Guan, Ling-Qin Song

Zhi-Jun Dai, Xi-Jing Wang, Hong-Tao Ren, Xiao-Xu Liu, Hua-Feng Kang, Hai-Tao Guan, Ling-Qin Song, Department of Oncology, the Second Affiliated Hospital, Medical School of Xi’an Jiaotong University, Xi’an 710004, Shaanxi Province, China

Zong-Fang Li, Zong-Zheng Ji, Department of General Surgery, the Second Affiliated Hospital, Medical School of Xi’an
Jiaotong University, Xi’an 710004, Shaanxi Province, China

Wei Tang, Department of life Science, Shaanxi Normal Uni-versity, Xi’an 710061, Shaanxi Province, China

Author contributions: Dai ZJ and Wang XJ designed the research; Dai ZJ, Li ZF, Ren HT, Tang W and Song LQ performed the research; Li ZF, Ji ZZ, Liu XX and Kang HF contributed to the reagents, materials, analysis; Dai ZJ and Guan HT analyzed the data; Dai ZJ and Ren HT wrote the paper.

Supported by The Science and Technology Foundation of Shaanxi Province, China, No. 2006K16-G5(1) and Sci-tech Program of Xi’an City, China, No. YF07175

Correspondence to: Dr. Zhi-Jun Dai, Department of Oncology, the Second Affiliated Hospital, Medical School of Xi’an Jiaotong University, No. 157, West 5th Road, Xi’an 710004, Shaanxi Province, China. 

Telephone: +86-29-87679526  Fax: +86-29-87679282

Received: October 13, 2008    Revised: November 24, 2008

Accepted: December 1, 2008

Published online: December 28, 2008



AIM: To study the growth inhibitory and apoptotic effects of Scutellaria barbata D.Don (S. barbata) and to determine the underlying mechanism of its antitumor activity in mouse liver cancer cell line H22.

METHODS: Proliferation of H22 cells was examined by MTT assay. Cellular morphology of PC-2 cells was observed under fluorescence microscope and transmission electron microscope (EM). Mitochondrial transmembrane potential was determined under laser scanning confocal microscope (LSCM) with rhodamine 123 staining. Flow cytometry was performed to analyze the cell cycle of H22 cells with propidium iodide staining. Protein level of cytochrome C and caspase-3 was measured by semi-quantitive RT-PCR and Western blot analysis. Activity of caspase-3 enzyme was measured by spectrofluorometry.

RESULTS: MTT assay showed that extracts from S. barbata (ESB) could inhibit the proliferation of H22 cells in a time-dependent manner. Among the various phases of cell cycle, the percentage of cells in S phase was significantly decreased, while the percentage of cells in G1 phase was increased. Flow cytometry assay also showed that ESB had a positive effect on apoptosis. Typical apoptotic morphologies such as condensation and fragmentation of nuclei and blebbing membrane of apoptotic cells could be observed under transmission electron microscope and fluorescence microscope. To further investige the molecular mechanism behind ESB-induced apoptosis, ESB-treated cells rapidly lost their mitochondrial transmembrane potential, released mitochondrial cytochrome C into cytosol, and induced caspase-3 activity in a dose-dependent manner.

CONCLUSION: ESB can effectively inhibit the proliferation and induce apoptosis of H22 cells involving loss of mitochondrial transmembrane potential, release of cytochrome C, and activation of caspase-3.


© 2008 The WJG Press. All rights reserved.


Key words: Scutellaria barbate; Hepatoma; Apoptosis; Mitochondrial transmembrane potential; Serum pha-rmacology


Peer reviewers: Debbie Trinder, PhD, School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, PO Box 480, Fremantle 6959, Western Australia, Australia; Dr. Katja Breitkopf, Department of Medicine II, University Hospital Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany


Dai ZJ, Wang XJ, Li ZF, Ji ZZ, Ren HT, Tang W, Liu XX, Kang HF, Guan HT, Song LQ. Scutellaria barbate extract induces apoptosis of hepatoma H22 cells via the mitochondrial pathway involving caspase-3. World J Gastroenterol 2008; 14(48): 7321-7328  Available from: URL:  DOI:



Scutellaria barbata D.Don (S. barbata) is a perennial herb, also known as Ban-Zhi-Lian (barbat sskullcap) in traditional Chinese medicine. It is mainly distributed in southern China and has been used as an antitumor agent for lung cancer, digestive system cancer, hepatoma, breast cancer, and chorioepithelioma as well as an anti-inflammatory agent and a diuretic in China and Korea[1-9]. Extracts from S. barbata (ESB) have in vitro growth inhibitory effects on a number of human cancers including leukemia, colon cancer, hepatoma and skin cancer[4-10]. However, its antitumor mechanism still remains unclear.

It was reported that many Chinese herbs have anticancer properties and induce apoptosis[11]. Three apoptotic pathways have been addressed, including the mitochondrial pathway[12,13], death receptor pathway[14], and endoplasmic reticulum stress-mediated apoptosis pathway[15]. The mitochondrial pathway initiates apoptosis in most physiological and pathological situations. Permeabilization outside mitochondrial membrane plays the most important role in mitochondrial apoptosis. In the mitochondria-initiated pathway, mitochondria undergoing permeability transition release apoptogenic proteins such as cytochrome C or apoptosis-inducing factor from the mitochondrial intermembrane space into the cytosol[16]. Released cytochrome C can activate caspase-9, and activated caspase-9 in turn cleaves and activates executioner caspase-3. After caspase-3 activation, some specific substrates for caspase-3 such as poly (ADP-ribose) and polymerase (PARP) are cleaved, and eventually lead to apoptosis[17].

In this study, S. barbata extract showed anti-tumor activity in vitro and could inhibit the growth of mouse H22 hepatoma cells by inhibiting cell apoptosis and cytotoxic effects, demonstrating that the extract from S. barbata can strongly inhibit cell proliferation and induce apoptosis of H22 cells through the mitochondrial dysfunction pathway.



Reagents and animals

New bovine serum (Gibco, USA), RPMI-1640 medium(Gibco, USA), propidium iodide (PI) (Sigma, USA), dimethyl sulfoxide (DMSO), ribonuclease (RNase A), rhodanmin123 (Rh123), and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenytetrazolium bromide (MTT) were purchased from Sigma Chemical (St. Louis, MO). Mouse monoclonal antibodies against caspase-3 and cytochrome C were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, USA). Apoptotic cell Hoechst 33258 detection kit was purchased from Nanjing Kai-ji Biotechnology Development Ltd (China), and fluorescence probes Rhodamine 123 was purchased from Sigma (USA). Male SD rats weighing 220-250 g were purchased from the Experiment Animal Center, Medical School of Xi’an Jiaotong University (China).


Preparation of S. barbata extract and drug containing serum  

S. barbata crude extract (ESB) was purchased from Xi’an Zhongxin Biotechnology Development Ltd (China). One kilogram of S. barbata was extracted three times with water as previously described[18]. Final qualification was 10:1. More specifically, stems of SB were cut into small pieces, boiled in water for 2 h, put into a filtrate, and concentrated by spray drying until the specific density reached 1.15-1.18.

“Serum pharmacology” was used to study the in vitro pharmacological activity of herb medicine as previously described[19]. ESB-containing serum was prepared as previously described[18,20]. Twenty male SD rats were randomly divided into control group, high ESB dose group, medium ESB dose group, and low ESB dose group (n = 5). Rats in the high, medium and low ESB dose groups received intragastric ESB of 6, 3 and 1.5 g/d per kg of body weight. Rats in the control group received normal saline, twice a day for 3 d. Two hours after the last administration, blood was immediately obtained from the heart and kept at room temperature for 4 h. The serum was separated by centrifugation at 2400 r/min for 10 min, collected following twice of filtration with a 0.22 mm cellulose acetate membrane, calefied in 56 water for 30 min, and stored at -20 for use.


Cell lines and culture

Mouse H22 hepatoma cells, purchased from Shanghai Institute of Cell Biology, Chinese Academy of Sciences (Shanghai, China), were cultured in RPMI-1640 medium (Gibco, USA) supplemented with 10% fetal bovine serum (Gibco, USA), 1 × 105 U/L penicillin and 100 mg/L streptomycin in an incubator containing a humidified atmosphere with 50 mL CO2 at 37. The cells were subcultured until reaching logarithmic growth phase. The viability of H22 cells, stained with trypan blue, was above 97%.


Cell viability assay

Cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) dye reduction assay (Sigma, USA). H22 cells were seeded at a concentration of 5 × 103 cells/well in a 96-well plate, and grown at 37 until adherence. At end of the treatment, 50 mg/10 mL of MTT was added and the cells were incubated for another 4 h. Two hundred mL of DMSO was added to each well after the supernatant was removed. After the plate was shaken for 10 min, cell viability was detected by measuring the absorbance at 490 nm wavelength using an enzyme-labeling instrument (EX-800 type) in quintuplicate.

Cell viability (%) = the absorbance of experimental group/the absorbance of blank control group × 100%.


Detection of morphological apoptosis

Staining of cells with uranyl acetate and lead citrate was performed to detect morphological changes. Briefly, adherent H22 cells were treated with ESB at a high dose for 48 h. The treated cells were digested with pancreatin and fixed in 3% glutaraldehyde precooled at 4 for 2 h. To make ultra-thin sections of copper, cells were washed with PBS, fixed in 1% osmic acid for an additional hour, dehydrated in acetone and embedded in epoxide resin. After stained with uranyl acetate and lead citrate, the sections were examined under a Hitachi-800 transmission electron microscope as previously described[21].


Nuclear staining

H22 cells were harvested by centrifugation, washed with PBS and fixed in 1% glutaraldehyde for 1 h at room temperature. The fixed cells were washed with PBS, stained with 200 mmol/L Hoechst 33258 for 10 min. Changes in nuclei after stained with Hoechst 33258 were observed under a fluorescence microscope (Olympus, BX-60, Japan).


Cell cycle analysis

H22 cells were incubated at 5 × 105 cells/well in 6-well plates, treated with a homologous drug for 48 h. The detached and attached cells were harvested and fixed in 70% ice-cold ethanol at -20 overnight. After fixation, cells were washed with PBS, resuspended in 1 mL PBS containing 1 mg/mL RNase (Sigma) and 50 mg/mL PI (Sigma), and incubated at 37 for 30 min in the dark. Samples of 10 000 cells were then analyzed for DNA content by FACScan flow cytometry (Beckman, USA), and cell cycle phase distributions were analyzed with the CellQuest acquisition software(BD Biosciences).


Detection of mitochondrial membrane potential

Mitochondria transmembrane potential (∆ψm) was detected under laser scanning confocal microscope(LSCM) with Rhodamine 123 (Rh123) staining as previously described[22]. About 1 × 106 cells were harvested by trypsinization, washed twice with PBS, and incubated with Rh123 at the final concentration of 1 mL/mL for 20 min at 37 in the dark, centrifuged at 1000 r/min for 5 min, washed twice with a medium, resuspended in the medium, cultured at 37 in an incubator containing 50 mL CO2 for 60 min. Fluorescence intensity was determined at an excitation wavelength of 488 nm, emission wavelength of 530 nm under a laser scanning confocal microscope (Olympus, FluoView™ FV300, Japan). The fluorescence intensity of Rhodamine 123 in cells represents the mitochondrial membrane potential[23].


Western blot analysis

H22 cells (2.5 × 107) were collected by centrifugation at 2000 r/min for 10 min at 4, washed twice with cold PBS (pH 7.2), centrifuged at 2000 r/min for 10 min. Protein content was determined using a Bio-Rad protein assay reagent with bovine serum albumin as the standard. Total proteins (30 mg/lane) were separated by 15% SDS-PAGE gel electrophoresis, and transferred to a 0.45 mm PVDF membrane (Amersham Pharmacia Biotech). The blots were incubated with the desired primary antibody overnight at the following dilutions: caspase 3 (1:1000), cytochrome C (1:1500), and b-actin (1:1500). Primary antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Subsequently, the membrane was incubated with appropriate secondary antibodies for 1 h at room temperature. The immunoblots were analyzed by densitometry on a GelDoc 2000 system (Bio-Rad Laboratories Inc. USA) as previously described[17,24].


Assay for caspase-3 activity

Caspase-3 activity was assayed using the caspase-3 activity assay kit (Nanjing Kai-ji, China) as previously described[25,26]. In brief, standard curve was plotted by detecting the absorbance of standard samples with terminal concentrations at each well, respectively. After 1 h incubation at room temperature, H22 cells were collected and lysed completely in a caspase assay buffer. The activity of caspase-3 was assayed in triplicate using a plate-reading luminometer (Turner Designs, Sunnyvale, CA) at the wavelength of 405 nm. Nkat was used to represent the activity measured[25].


Statistical analysis

All data were expressed as mean  ±  SD. Statistical analysis was performed with analysis of variance (ANOVA) using the statistical software SPSS 11.0. P < 0.05 was considered statistically significant.



Effect of ESB on proliferation of H22 cells 

H22 cells were treated with different doses of ESB.The growth rate of H22 cells was evaluated after 0, 24, 48, 72, and 96 h, respectively. The cell viability of H22 cells in different ESB treatment groups was significantly higher than that in 5-FU treatment group (Figure 1). High and medium dose ESB inhibited the proliferation of H22 cells (P < 0.05), while low dose ESB could not obviously inhibit the proliferation of H22 cells (P > 0.05). MTT assay showed that high and medium dose ESB inhibited the proliferation of H22 cells in vitro in a time-dependent manner.


Morphological observation of apoptosis of H22 cells induced by ESB

High resolution transmission electron microscopy showed that normal H22 cells were round and regular in shape with chromatin margination in few tumor cells (Figure 2A). After treatment with a high ESB dose for 48 h, a part of nuclear membrane domed outward with a sharp angle. The typical morphologies of apoptotic H22 cells such as chromatic agglutination and fragmentation of nuclei, chondriosome swelling, formation of apoptotic body, could be observed in high ESB dose group (Figure 2B-D), while in 5-FU group, cellular swelling and necrosis could be observed in many fields of vision.


Detection of apoptosis of H22 cells by Hoechst 33258 staining

After treatment with different doses of ESB for 48 h, H22 cells were stained with Hoechst 33258 and observed under a fluorescence microscope. The condensely stained chromatin of apoptotic cells was more bright than that of normal cells. The characteristics of apoptosis, such as nuclear shrinkage, DNA condensation and fragmentation, were found in ESB treatment group (Figure 3B-D), while no apoptosis occurred in blank control group (Figure 3A). The percentage of apoptotic cells in control group and low and high ESB dose groups was 3.36% ± 2.14%, 14.57% ± 4.28%, 43.15% ± 5.33%, 72.65% ± 6.52%, respectively. Furthermore, the number of apoptotic cells gradually increased in a dose-dependent manner.


Effect of ESB on cell cycle distribution by flow cytometry

The effects of ESB on cell cycles were analyzed by flow cytometry. The percentage of cells was significantly decreased at S phase and increased at G1 phase in high ESB dose group.

The sub-G1 population indicated apoptotic-associated chromatin degradation. The ratio of cell apoptosis in blank control group, and low, medium, high ESB dose groups was 0.51%, 1.07%, 3.15%, 7.83%, respectively. There was significantly difference between the 4 groups (P < 0.05). These results suggest that high ESB dose can induce cell cycle arrest at G0/G1 phase and apoptosis in H22 cells (Table 1).


Effect of ESB on mitochondrial membrane potential

Mitochondria play an essential role in apoptosis. To assess whether ESB affects the function of mitochondria, mitochondrial membrane potential was detected under a laser scanning confocal microscope with Rh123 staining. The fluorescence intensity of Rhodamine123 in H22 cells of blank control group was the strongest (Figure 4). After treatment with different doses of ESB for 48 h, ANOVA analysis showed that the fluorescence intensity was decreased in a dose-dependent manner (P < 0.05).


Caspase-3 activity in ESB-induced apoptosis of H22 cells

Caspase-3, acting on downstream of the mitochondrial signaling pathway, is a major mediator of apoptosis. Dysfunction of mitochondria provoked us to detect the changes of caspase-3 activity in H22 cells following ESB treatment. The expression intensities of caspase-3 protein in the control and low-high ESB dose groups were 0.21 ± 0.02, 0.33 ± 0.04, 0.59 ± 0.03, and 0.85 ± 0.05, respectively (Figure 5). Western blot analysis revealed that there was a gradual increase in caspase-3 protein in low-high ESB dose groups (P < 0.05), indicating that caspase-3 can be activated by ESB.

Caspase-3 activities were detected after treatment with different doses of ESB for 48 h, showing that caspase-3 activity was induced by ESB in a dose-dependent manner (Figure 6).


Release of cytochrome C from mitochondria in ESB-induced apoptosis

Cytochrome C release from mitochondria into cytosol is a critical step in the apoptotic cascade. The reduction of mitochondrial membrane potential may facilitate the release of cytochrome C, which will then activate the apoptotic pathway to trigger cell death. The protein level of cytochrome C in cytosol was measured in H22 cells treated with different doses of ESB by Western blot analysis with mouse monoclonal cytochrome C antibodies. As shown in Figure 5, the amount of cytosolic cytochrome C in the cytosolic fraction after ESB treatment was significantly increased in a dose-dependent manner (P < 0.05).



S. barbata, which has been traditionally used in treatment of inflammation, hepatitis, tumor and gynecological diseases in China and Korea[1-9]. Studies have shown that S. barbata contains a large number of alkaloids and flavones, alkaloid, sterides, and polysaccharides[27,28]. However, the active site of chemical structure for antitumor activity has not been fully determined[29]. Recent studies indicate that S. barbata extract (ESB) is effective against hepatoma, lung and digestive system cancers, et al[4-10], and can be used in combination with other traditional Chinese medicines in treatment of other tumors.

In pharmacology study, crude Chinese drugs or their compounds are often added directly into the culture system of cells or organs in vitro[30]. However,, experimental results in vitro are often different from those in vivo. Serum pharmacology has been extensively used to study the effects and mechanisms of Chinese drugs in vitro[30]. It is believed that serum pharmacology is more scientific and beter for Chinese drugs than traditional pharmacology in which crude drugs are directly added into the culture system of cells or organs in vitro[19-20,30,31]. In this study, we investigated the effects of ESB on inducing apoptosis of H22 cells with serum pharmacology.

H22 cells were treated with different doses of ESB containing serum, and the growth rate of H22 cells was evaluated by MTT assay after 0, 24, 48, 72, and 96 h, respectively. High and medium ESB dose inhibited the proliferation of H22 cells, while low ESB dose could not obviously inhibit the proliferation of H22 cells. MTT assay showed high and medium ESB dose inhibited the proliferation of H22 cells in vitro in a time-dependent manner, which may provide useful information for development of anti-tumor drugs.

Morphological changes of apoptosis include membrane blebbing, cell shrinkage, chromatin conden-sation, DNA fragmentation and formation of apoptotic bodies[32]. These morphological changes were also observed in our study under transmission electron microscopy and fluorescence microscope after treatment with a high ESB dose for 48 h. Typical morphologies of apoptotic H22 cells, such as chromatic agglutination and fragmentation of nuclei, chondriosome swelling, formation of apoptotic body, were observed in ESB high ESB dose group (Figure 2B-D), but no apoptosis occurred in blank control group. Furthermore, fluorescence microscopy showed that the number of apoptotic cells gradually increased in a dose-dependent manner.

Blocking of cell cycle is one of the mechanisms of ESB by which the growth and proliferation of tumor cells are inhibited[33]. Flow cytometry showed that cell apoptosis was significantly decreased at S-phase, increased at G1-phase, and reached its peak at subG1- phase. The blocking of cell cycle may be one of the mechanisms of ESB by which the growth of H22 cells is inhibited and cell apoptosis is induced.

Mitochondria play a critical role in apoptosis induced by chemotherapeutic agents[12-14]. Many agents can induce, directly or indirectly, apoptosis by insult to the mitochondria[34,35]. Apoptosis could cause loss of Δψm and release of cytochrome C into cytosol, and induce caspase-9-dependent activation of caspase-3[13]. In this study, the effect of ESB on Δψm was examined using Rhodamine 123, a mitochondrial potential probe, showing that H22 cells lost Δψm following ESB treatment. Forty-eight hours after ESB treatment, the cells exhibited significant alterations in Δψm, and the fluorescence intensity of disruption of Δψm gradually decreased in a dose-dependent manner

One of the major apoptotic pathways is activated by the release of cytochrome C from mitochondria into cytosol[36], which is the hallmark of cells undergoing apoptosis. In this study, Western blotting analysis was performed to measure the protein level of cytochrome C in H22 cells after treatment with different doses of ESB. The amount of cytosolic cytochrome C in the cytosolic fraction after ESB treatment was increased in a dose-dependent manner (Figure 6).

Caspases are cystein proteases that play a key role in the execution phase of apoptosis[37]. Caspase-3, a member of the family of caspases, extensively studied as “the executor of apoptosis”, plays a crucial role in cell death[38]. Apoptosis mediated by caspase-3 occurs in many cancer cells. In this study, Western blot analysis revealed that caspase-3 protein was gradually increased in the low-high ESB dose groups. At the same time, caspase-3 enzyme activity was increased in a dose-dependent manner. These results indicate that caspase-3 can be activated by ESB. ESB treatment resulted in loss of mitochondrial membrane potential, release of cytochrome C and caspase-3, demonstrating that ESB induces apoptosis and mitochondria are involved in apoptosis mediated by ESB.

In conclusion, ESB has antiproliferative activities against H22 cells by inducing apoptosis involving loss of ∆ψm, release of cytochrome C, and activation of caspase-3.




Medicinal plants have been used as traditional remedies for hundreds of years. Among them, Scutellaria barbata D.Don (S. barbata) has been traditionally used in treatment of hepatitis, inflammation, osteomyelitis and gynecological diseases in China. Studies indicate that extracts from S. barbata have growth inhibitory effects on a number of human cancers. Reports are available on the treatment of lung, breast and digestive system cancer, hepatoma, and chorioepithelioma with S. barbata extracts. However, the underlying mechanism of the antitumor activity of S. barbata extracts remains unclear.

Research frontiers

Studies have confirmed that many Chinese herbs have antitumor properties and induce apoptosis. In the process of signal transduction of cell apoptosis induced by drugs, mitochondria play a great role in promoting apoptosis signal and releasing caspase. Permeabilization of the outside mitochondrial membrane plays the most important role in mitochondrial apoptosis, during which loss of Δψm and release of cytochrome C into cytosol, and caspase-9- dependent activation of caspase-3 occur sequentially.

Innovations and breakthroughs

There is no evidence that the mitochondrial pathway is involved in apoptosis induced by S. barbata. The present study was undertaken by culturing mouse liver cancer H22 cells treated with serum containing different concentrations of ESB. ESB containing serum induced apoptosis of H22 cells, and apoptosis was involved in loss of mitochondrial transmembrane potential, release of cytochrome C, and activation of caspase-3.


This experimental study on the mechanism of the antitumor activity of S. barbata, may offer new evidence for S. barbata in the treatment of hepatoma in clinical practice.


ESB is an extract from Scutellaria barbata; ∆ψm indicates mitochondrial transmembrane potential;1 nanokatal defined as the amount of enzyme required to increase the rate of reaction by 1 nmol/s under defined assay conditions.

Peer review

This study examined the anti-tumour effects of Scutellaria barbate. The authors used serum containing extract from S. Barbata (ESB) to determine its effect on proliferation of H22 hepatoma cells in vitro. ESB inhibited cell proliferation by inducing cell cycle arrest at Go/G1 phase and by increasing apoptosis with a reduction in mitochondrial membrane potential, release of cytochrome C and capase-3 activation. This work is novel and improves our understanding of the mechanisms of action of ESB.



1      Lee TK, Lee DK, Kim DI, Lee YC, Chang YC, Kim CH. Inhibitory effects of Scutellaria barbata D. Don on human uterine
  leiomyomal smooth muscle cell proliferation through cell cycle analysis. Int Immunopharmacol 2004; 4: 447-454
PubMed   DOI

2      Lin CC, Shieh DE. The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin,
  baicalein and wogonin. Am J Chin Med 1996; 24: 31-36  
PubMed   DOI

3      Lee TK, Kim DI, Song YL, Lee YC, Kim HM, Kim CH. Differential inhibition of Scutellaria barbata D. Don (Lamiaceae) on
  HCG-promoted proliferation of cultured uterine leiomyomal and myometrial smooth muscle cells. Immunopharmacol
2004; 26: 329-342  
PubMed   DOI

4      Goh D, Lee YH, Ong ES. Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon
  cancer cell lines, LoVo. J Agric Food Chem 2005; 53: 8197-8204
   PubMed   DOI

5      Yin X, Zhou J, Jie C, Xing D, Zhang Y. Anticancer activity and mechanism of Scutellaria barbata extract on human lung
  cancer cell line A549. Life Sci 2004; 75: 2233-2244  
PubMed   DOI

6      Cha YY, Lee EO, Lee HJ, Park YD, Ko SG, Kim DH, Kim HM, Kang IC, Kim SH. Methylene chloride fraction of Scutellaria
  barbata induces apoptosis in human U937 leukemia cells via the mitochondrial signaling pathway. Clin Chim Acta 2004;
: 41-48  
PubMed   DOI

7      Suh SJ, Yoon JW, Lee TK, Jin UH, Kim SL, Kim MS, Kwon DY, Lee YC, Kim CH. Chemoprevention of Scutellaria bardata
  on human cancer cells and tumorigenesis in skin cancer. Phytother Res 2007; 21: 135-141  
PubMed   DOI

8      Dai ZJ, Liu XX, Xue Q, Ji ZZ, Wang XJ, Kang HF, Guan HT, Ma XB, Ren HT. [Anti-proliferative and apoptosis-inducing
  activity of Scutellaria barbate containing serum on mouse’s hepatoma H22 cells] Zhongyaocai 2008; 31: 550-553

9      Lin JM, Liu Y, Luo RC. [Inhibition activity of Scutellariae barbata extracts against human hepatocellular carcinoma cells]
  Nanfang Yikedadue Xuebao
2006; 26: 591-593  

10    Lee TK, Cho HL, Kim DI, Lee YC, Kim CH. Scutellaria barbata D. Don induces c-fos gene expression in human uterine
  leiomyomal cells by activating beta2-adrenergic receptors. Int J Gynecol Cancer 2004; 14: 526-531  
PubMed   DOI

11    Yu ZH, Wei PK, Xu L, Qin ZF, Shi J. Anticancer effect of jinlongshe granules on in situ-transplanted human MKN-45
  gastric cancer in nude mice and xenografted sarcoma 180 in Kunming mice and its mechanism. World J Gastroenterol
2006; 12: 2890-2894  

12    Mohamad N, Gutierrez A, Nunez M, Cocca C, Martin G, Cricco G, Medina V, Rivera E, Bergoc R. Mitochondrial apoptotic
  pathways. Biocell 2005; 29: 149-161  

13    Delivani P, Martin SJ. Mitochondrial membrane remodeling in apoptosis: an inside story. Cell Death Differ 2006; 13:
PubMed   DOI

14    Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int J Oncol 2003; 22:

15    Bakhshi J, Weinstein L, Poksay KS, Nishinaga B, Bredesen DE, Rao RV. Coupling endoplasmic reticulum stress to the cell
  death program in mouse melanoma cells: effect of curcumin. Apoptosis 2008; 13: 904-914  
PubMed   DOI

16    Hoye AT, Davoren JE, Wipf P, Fink MP, Kagan VE. Targeting mitochondria. Acc Chem Res 2008; 41: 87-97   PubMed 

17    Li H, Wang LJ, Qiu GF, Yu JQ, Liang SC, Hu XM. Apoptosis of Hela cells induced by extract from Cremanthodium humile.
  Food Chem Toxicol
2007; 45: 2040-2046  
PubMed   DOI

18    Zhang YH, Liu JT, Wen BY, Xiao XH. In vitro inhibition of proliferation of vascular smooth muscle cells by serum of rats
  treated with Dahuang Zhechong pill. J Ethnopharmacol 2007; 112: 375-379  
PubMed   DOI

19    Miura D, Miura Y, Yagasaki K. Effect of apple polyphenol extract on hepatoma proliferation and invasion in culture and
  on tumor growth, metastasis, and abnormal lipoprotein profiles in hepatoma-bearing rats. Biosci Biotechnol Biochem
  2007; 71: 2743-2750  
PubMed   DOI

20    Nishida S, Satoh H. Mechanisms for the vasodilations induced by Ginkgo biloba extract and its main constituent,
  bilobalide, in rat aorta. Life Sci 2003; 72: 2659-2667  
PubMed   DOI

21    Ma G, Yang C, Qu Y, Wei H, Zhang T, Zhang N. The flavonoid component isorhamnetin in vitro inhibits proliferation and
  induces apoptosis in Eca-109 cells. Chem Biol Interact 2007; 167: 153-160  
PubMed   DOI

22    Zhao JX, Guo FL, Bai DC, Wang XX. [Effects of fuzheng yiliu granules on apoptotic rate and mitochondrial membrane
  potential of hepatocellular carcinoma cell line H22 from mice] Zhongxiyi Jiehe Xuebao 2006; 4: 271-274  
PubMed   DOI

23    Blattner JR, He L, Lemasters JJ. Screening assays for the mitochondrial permeability transition using a fluorescence
  multiwell plate reader. Anal Biochem 2001; 295: 220-226  
PubMed   DOI

24    Chen CJ, Hsu MH, Huang LJ, Yamori T, Chung JG, Lee FY, Teng CM, Kuo SC. Anticancer mechanisms of YC-1 in human
  lung cancer cell line, NCI-H226. Biochem Pharmacol 2008; 75: 360-368  
PubMed   DOI

25    Feeney B, Pop C, Swartz P, Mattos C, Clark AC. Role of loop bundle hydrogen bonds in the maturation and activity of
  (Pro)caspase-3. Biochemistry 2006; 45: 13249-13263  
PubMed   DOI

26    Peng B, Chang Q, Wang L, Hu Q, Wang Y, Tang J, Liu X. Suppression of human ovarian SKOV-3 cancer cell growth by
  Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis. Gynecol Oncol 2008; 108: 173-181

        PubMed   DOI

27    Wang WS, Zhou YW, Ye YH, Du N. [Studies on the flavonoids in herb from Scutellaria barbata] Zhongguo Zhongyao
2004; 29: 957-959  

28    Dai SJ, Sun JY, Ren Y, Liu K, Shen L. Bioactive ent-clerodane diterpenoids from Scutellaria barbata. Planta Med 2007;
: 1217-1220  
PubMed   DOI

29    Yu J, Lei J, Yu H, Cai X, Zou G. Chemical composition and antimicrobial activity of the essential oil of Scutellaria barbata.
2004; 65: 881-884
   PubMed   DOI

30    Bochu W, Liancai Z, Qi C. Primary study on the application of Serum Pharmacology in Chinese traditional medicine.
  Colloids Surf B Biointerfaces
2005; 43: 194-197
   PubMed   DOI

31    Er HM, Cheng EH, Radhakrishnan AK. Anti-proliferative and mutagenic activities of aqueous and methanol extracts of
  leaves from Pereskia bleo (Kunth) DC (Cactaceae). J Ethnopharmacol 2007; 113: 448-456
   PubMed   DOI

32    Rello S, Stockert JC, Moreno V, Gamez A, Pacheco M, Juarranz A, Canete M, Villanueva A. Morphological criteria to
  distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis 2005; 10: 201-208
   PubMed   DOI

33    Sigounas G, Hooker J, Anagnostou A, Steiner M. S-allylmercaptocysteine inhibits cell proliferation and reduces the
  viability of erythroleukemia, breast, and prostate cancer cell lines. Nutr Cancer 1997; 27: 186-191

34    Fulda S, Susin SA, Kroemer G, Debatin KM. Molecular ordering of apoptosis induced by anticancer drugs in
  neuroblastoma cells.
Cancer Res 1998; 58: 4453-4460   PubMed 

35    Kim KC, Kim JS, Son JK, Kim IG. Enhanced induction of mitochondrial damage and apoptosis in human leukemia HL-60
  cells by the Ganoderma lucidum and Duchesnea chrysantha extracts. Cancer Lett 2007; 246: 210-217
   PubMed   DOI

36    Lalier L, Cartron PF, Juin P, Nedelkina S, Manon S, Bechinger B, Vallette FM. Bax activation and mitochondrial insertion
  during apoptosis. Apoptosis 2007; 12: 887-896
   PubMed   DOI

37    Chen YC, Shen SC, Lee WR, Hsu FL, Lin HY, Ko CH, Tseng SW. Emodin induces apoptosis in human promyeloleukemic
  HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production.
  Biochem Pharmacol
2002; 64: 1713-1724
   PubMed   DOI

38    Park SY, Cho SJ, Kwon HC, Lee KR, Rhee DK, Pyo S. Caspase-independent cell death by allicin in human epithelial
  carcinoma cells: involvement of PKA. Cancer Lett 2005; 224: 123-132


S- Editor  Tian L    L- Editor  Wang XL    E- Editor  Ma WH






Reviews Add

Related Articles:
Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy
Inhibitory effect of IGF- II antisense RNA on malignant phenotype of hepatocellular carcinoma
Analysis of in vivo patterns of caspase 3 gene expression in primary hepatocellular carcinoma and its relationship to p21WAF1 expression and hepatic apoptosis
Hepatocellular carcinoma in central Sydney:a 10-year review of patients seen in a medical oncology department
Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks